JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 77 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $836,420 | +69.4% | 452,119 | +1.7% | 0.00% | – |
| Q4 2022 | $493,639 | -58.4% | 444,720 | -12.4% | 0.00% | -100.0% |
| Q3 2022 | $1,187,000 | +356.5% | 507,406 | +491.8% | 0.00% | – |
| Q2 2022 | $260,000 | -52.6% | 85,735 | +6.0% | 0.00% | – |
| Q1 2022 | $549,000 | +30.1% | 80,857 | +59.8% | 0.00% | – |
| Q4 2021 | $422,000 | +199.3% | 50,592 | +166.9% | 0.00% | – |
| Q3 2021 | $141,000 | +6.0% | 18,957 | -3.1% | 0.00% | – |
| Q2 2021 | $133,000 | +15.7% | 19,571 | +74.5% | 0.00% | – |
| Q1 2021 | $115,000 | +33.7% | 11,216 | -8.5% | 0.00% | – |
| Q4 2020 | $86,000 | +19.4% | 12,257 | +39.6% | 0.00% | – |
| Q3 2020 | $72,000 | +30.9% | 8,782 | +10.6% | 0.00% | – |
| Q2 2020 | $55,000 | +71.9% | 7,943 | +18.7% | 0.00% | – |
| Q1 2020 | $32,000 | -90.8% | 6,691 | -83.3% | 0.00% | – |
| Q4 2019 | $348,000 | +25.6% | 40,070 | -52.0% | 0.00% | – |
| Q3 2019 | $277,000 | -51.3% | 83,562 | -27.4% | 0.00% | – |
| Q2 2019 | $569,000 | -43.6% | 115,151 | -29.3% | 0.00% | -100.0% |
| Q1 2019 | $1,008,000 | +99.2% | 162,852 | +8.4% | 0.00% | – |
| Q4 2018 | $506,000 | -63.1% | 150,295 | -28.8% | 0.00% | – |
| Q3 2018 | $1,372,000 | +128.7% | 211,191 | +169.6% | 0.00% | – |
| Q2 2018 | $600,000 | +2.6% | 78,323 | +198.5% | 0.00% | – |
| Q1 2018 | $585,000 | +40.6% | 26,236 | -19.7% | 0.00% | – |
| Q4 2017 | $416,000 | +28.8% | 32,676 | +56.6% | 0.00% | – |
| Q3 2017 | $323,000 | +70.9% | 20,871 | +53.0% | 0.00% | – |
| Q2 2017 | $189,000 | +6.8% | 13,638 | +68.5% | 0.00% | – |
| Q1 2017 | $177,000 | – | 8,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 662,063 | $10,315,000 | 30.07% |
| Omega Fund Management, LLC | 579,650 | $9,031,000 | 5.11% |
| Casdin Capital, LLC | 399,825 | $6,229,000 | 1.76% |
| Cormorant Asset Management, LP | 359,738 | $5,605,000 | 0.99% |
| Foresite Capital Management II, LLC | 119,912 | $1,868,000 | 0.76% |
| Redmile Group, LLC | 955,598 | $14,888,000 | 0.73% |
| PFM Health Sciences, LP | 1,727,997 | $26,922,000 | 0.53% |
| Fosun International Ltd | 285,960 | $4,455,000 | 0.44% |
| Partner Investment Management, L.P. | 14,265 | $222,000 | 0.21% |
| Spark Investment Management LLC | 162,200 | $2,527,000 | 0.14% |